Acne vaccines: Therapeutic option for the treatment of acne vulgaris?

Journal of Investigative Dermatology

Volumn 128, Issue 10, 2008, Pages 2353-2354

  Kim, Jenny ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE VACCINE; IMIQUIMOD; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG; VACCINE;

ACNE VULGARIS; BACTERIAL GROWTH; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG MECHANISM; HUMAN; IMMUNIZATION; IMMUNOMODULATION; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACNE VULGARIS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; HUMANS; PROPIONIBACTERIUM ACNES;

EID: 51749090866     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.221     Document Type: Note

References (11)

1. Ashbee HR, Muir SR, Cunliffe WJ, Ingham E (1997) IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris. Br J Dermatol 136:730-3
2. Ingham E, Gowland G, Ward RM, Holland KT, Cunliffe WJ (1987) Antibodies to P. acnes and P. acnes exocellular enzymes in the normal population at various ages and in patients with acne vulgaris. Br J Dermatol 116:805-12
3. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ et al. (2002) Activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169:1535-41
4. Leyden JJ, McGinley KJ, Vowels B (1988) Propionibacterium acnes colonization in acne and non-acne. Dematology 196:55-8
5. Liu PT, Krutzik SR, Kim J, Modlin RL (2005) Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. J Immunol 174:2467-70
6. Liu PT, Phan J, Tang D, Kanchanapoomi M, Hall B, Krutzik SR et al. (2008) CD 209+ macrophages mediate host defense against Propionibacterium acnes. J Immunol 190:4919-23
7. Nagy I, Pivarcsi A, Koreck A, Szell M, Urban E, Kemeny L (2005) Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through Toll-like receptors. J Invest Dermatol 124:931-8
8. Nagy I, Pivarcsi A, Kis K, Koreck A, Bodai L, McDowell A et al. (2006) Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 8:2195-205
9. Nakatsuji T, Liu Y-T, Huang C-P, Gallo RL, Huang C-M (2008a) Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris. PloS ONE 3:e1551
10. Nakatsuji T, Liu Y-T, Huang C-P, Gallo RL, Huang C-M (2008b) Antibodies elicited by inactivated P. acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris. J Invest Dermatol 128:2451-2457
11. Webster GF, Indrisano JP, Leyden JJ (1985) Antibody titers to Propionibacterium acnes cell wall carbohydrate in nodulocystic acne patients. J Invest Dermatol 84:496-500